CORC

在结果中检索

CORC

浏览/检索结果: 共31条，第1-10条 帮助

已选(0)清除 条数/页：   排序方式：
Significant delta Ca-44/40 variations between carbonate- and clay-rich marine sediments from the Lesser Antilles forearc and implications for mantle heterogeneity 期刊论文
GEOCHIMICA ET COSMOCHIMICA ACTA, 2020, 卷号: 276, 页码: 239-257
作者:  Zhu, Hongli;  Liu, Fang;  Li, Xin;  An, Yajun;  Nan, Xiaoyun
收藏  |  浏览/下载：13/0  |  提交时间：2020/09/23
Significant delta Ca-44/40 variations between carbonate- and clay-rich marine sediments from the Lesser Antilles forearc and implications for mantle heterogeneity 期刊论文
GEOCHIMICA ET COSMOCHIMICA ACTA, 2020, 卷号: 276, 页码: 239-257
作者:  Zhu, Hongli;  Liu, Fang;  Li, Xin;  An, Yajun;  Nan, Xiaoyun
收藏  |  浏览/下载：5/0  |  提交时间：2021/11/10
Nitrogen Transformation during Pyrolysis of Various N-Containing Biowastes with Participation of Mineral Calcium 期刊论文
ACS SUSTAINABLE CHEMISTRY & ENGINEERING, 2020, 卷号: 8, 期号: 32, 页码: 12197-12207
作者:  Nan, Hongyan;  Xiao, Ziyue;  Zhao, Ling;  Yang, Fan;  Xu, Huacheng
收藏  |  浏览/下载：9/0  |  提交时间：2021/11/15
Barium isotopic fractionation in latosol developed from strongly weathered basalt 期刊论文
SCIENCE OF THE TOTAL ENVIRONMENT, 2019, 卷号: 687, 页码: 1295-1304
作者:  Gong, Yingzeng;  Zeng, Zhen;  Zhou, Chen;  Nan, Xiaoyun;  Yu, Huimin
收藏  |  浏览/下载：18/0  |  提交时间：2020/06/05
Efficacy and Safety of All-Oral, 12-Week Ravidasvir Plus Ritonavir-Boosted Danoprevir and Ribavirin in Treatment-Naive Non-Cirrhotic HCV Genotype 1 Patients : Results from a Phase 2/ 3 Clinical Trial in China 期刊论文
HEPATOLOGY, 2018, 卷号: 68
作者:  Wei, Lai;  Xu, Xiaoyun;  Guan, Yujuan;  Zheng, Sujun;  Sheng, Jifang
收藏  |  浏览/下载：21/0  |  提交时间：2019/12/05
Efficacy and Safety of All-Oral, 12-Week Ravidasvir Plus Ritonavir-Boosted Danoprevir and Ribavirin in Treatment-Naive Non-Cirrhotic HCV Genotype 1 Patients : Results from a Phase 2/ 3 Clinical Trial in China 会议论文
作者:  Wei, Lai;  Xu, Xiaoyun;  Guan, Yujuan;  Zheng, Sujun;  Sheng, Jifang
收藏  |  浏览/下载：11/0  |  提交时间：2019/12/05
Efficacy and Safety of All-Oral, 12-Week Ravidasvir Plus Ritonavir-Boosted Danoprevir and Ribavirin in Treatment-Naive Non-Cirrhotic HCV Genotype 1 Patients : Results from a Phase 2/ 3 Clinical Trial in China 会议论文
作者:  Wei, Lai;  Xu, Xiaoyun;  Guan, Yujuan;  Zheng, Sujun;  Sheng, Jifang
收藏  |  浏览/下载：11/0  |  提交时间：2019/11/19
Lipid-modified Cell-Penetrating Peptide-Based Self-assembly Micelles for Co-delivery of Narciclasine and siULK1 in Hepatocellular Carcinoma Therapy. 期刊论文
Acta biomaterialia, 2018
作者:  Wang Xiaoyun;  Wu Fengbo;  Li Guoyou;  Zhang Nan;  Song Xiangrong
收藏  |  浏览/下载：8/0  |  提交时间：2019/02/25
Efficacy and Safety of All-Oral, 12-Week Ravidasvir Plus Ritonavir-Boosted Danoprevir and Ribavirin in Treatment-Naive Non-Cirrhotic HCV Genotype 1 Patients : Results from a Phase 2/ 3 Clinical Trial in China 会议论文
作者:  Wei, Lai;  Xu, Xiaoyun;  Guan, Yujuan;  Zheng, Sujun;  Sheng, Jifang
收藏  |  浏览/下载：10/0  |  提交时间：2019/12/05
Lipid-modified cell-penetrating peptide-based self-assembly micelles for co-delivery of narciclasine and siULK1 in hepatocellular carcinoma therapy 期刊论文
2018, 卷号: 74, 页码: 414-429
作者:  Wang, Xiaoyun[1,2,3];  Wu, Fengbo[1,2,3];  Li, Guoyou[4];  Zhang, Nan[1,2,3];  Song, Xiangrong[1,2,3]
收藏  |  浏览/下载：4/0  |  提交时间：2019/12/06

©版权所有 ©2017 CSpace - Powered by CSpace